While such compounds have been described, none have yet been considered credible pharmacological candidates (253, 254) due to a combination of factors, including insufficient potency, lack of specificity of binding to the GLP-1R and suboptimal half-life
Outcomes differ from person to person, but consistency, provider oversight, and lifestyle choices all play an important role
However, it's crucial to note that compounded peptides are not FDA-approved and do not qualify for insurance coverage
However, we acknowledge the potential limitations of ultra-long-acting insulin preparations, including the risk of exacerbating insulin resistance in diabetic patients
Thyroid Tumors In animal studies, GLP-1 drugs have been linked to thyroid C-cell tumors
Yes, it's safe during pregnancy at recommended doses